Advertisement
Advertisement
GoodRx Holdings, Inc. (GDRX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 5.95 |
| Open | 6.01 |
| Bid | 6.00 x 1200 |
| Ask | 6.29 x 2900 |
| Day's Range | 5.95 - 6.31 |
| 52 Week Range | 3.82 - 20.59 |
| Volume | |
| Avg. Volume | 1,713,190 |
| Market Cap | 2.485B |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 |
| Earnings Date | May 08, 2023 - May 12, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.93 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Subscribe to Yahoo Finance Plus to view Fair Value for GDRX
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- GoodRx Holdings, Inc.Analyst Report: GoodRx Holdings, Inc.GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.RatingFair ValueEconomic Moat9 months agoMorningstar
- Motley Fool
These 2 Stocks Crashed 85% Last Year But Are off to Hot Starts in 2023
Many growth stocks did even worse in 2022, including Coinbase Global (NASDAQ: COIN) and GoodRx (NASDAQ: GDRX), which each saw their share prices collapse by more than 85% over the course of the year. Coinbase runs a platform for buying and selling cryptocurrencies. Because of that, its stock performance tends to be closely related to the popularity of Bitcoin.
- Simply Wall St.
Is Now The Time To Look At Buying GoodRx Holdings, Inc. (NASDAQ:GDRX)?
GoodRx Holdings, Inc. ( NASDAQ:GDRX ), is not the largest company out there, but it led the NASDAQGS gainers with a...
- Zacks
Teladoc's (TDOC) BetterHelp Faces FTC Hurdle, to Pay $7.8M
Teladoc's (TDOC) BetterHelp business is expected to continue implementing more comprehensive privacy standards.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
